Heart disease continues to be the leading cause of death for both men and women in the United States.
One American dies every 40 seconds of cardiovascular disease (CVD), which causes one in every three deaths in the US. This year, over 630,000 Americans will have a heart attack for the first time and 280,000 will have a recurrent heart attack.
While these numbers are staggering in an age of modern medicine, the medical community has largely been reactive only with a record number of stent placement procedures and coronary artery bypass surgeries being performed each year.
At LVWellness & Aesthetics, we believe most people who develop CVD could have prevented it in the first place with appropriate and timely cardiovascular screenings.
We believe that lab testing as well as lifestyle modifications through hormonal optimization, dietary changes, exercise and weight loss can make a huge impact in cardiovascular health.
We evaluate the following lipids and inflammatory risk factors through Boston Heart Diagnostics & covered by MOST Insurance companies:
ApoB is the primary apolipoprotein found on the surface of LDL (the carrier of “bad” cholesterol), IDL (intermediate-density lipoprotein), VLDL (very low-density lipoprotein) and Lp(a) (lipoprotein (a)). ApoB acts as a magnet for LDL receptors on various cells throughout the body, thereby regulating cholesterol influx into tissues. ApoA1 is the major apolipoprotein of HDL (the carrier of “good” cholesterol) and promotes cholesterol efflux from the artery wall to the liver for excretion.
The largest HDL subclass particles are associated with the cardioprotective function of HDL. Higher levels translate to lower cardiac risk.
LDL, which carries “bad” cholesterol, exists either as large, more buoyant particles or as smaller, more dense particles (sdLDL). sdLDL is more easily oxidized, has a higher affinity for vessel walls, and remains in the circulation longer because it is less likely to be cleared by the liver, making it more atherogenic than larger LDL particles.
High levels of lipoprotein(a) contribute to atherosclerosis and is not typically helped by statin medications.
This is a marker for vascular inflammation. High levels indicate increased risk for heart disease and stroke particularly if blood pressure and CRP are also elevated.
Useful in evaluating those at moderate risk for heart disease and determining if more intensive treatment is warranted.
Homocysteine is an amino acid inflammatory marker that if elevated has shown a correlation with increased cardiac risk. May be controlled by B-vitamin supplementation.